Deutsche Bank Ag\ Immucell Corp Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.79 - $5.92 $1,561 - $2,439	-412 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.81 - $5.57 $1,981 - $2,294	412 New	412 $2,000
Q4 2018 Feb 14, 2019	SELL	$6.4 - $9.03 $28,800 - $40,635	-4,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$6.5 - $8.99 $650 - $899	-100 Reduced 2.17%	4,500 $37,000
Q2 2018 Aug 14, 2018	BUY	$6.75 - $8.28 $11,468 - $14,067	1,699 Added 58.57%	4,600 $31,000
Q1 2018 May 15, 2018	SELL	$6.93 - $8.27 $16,625 - $19,839	-2,399 Reduced 45.26%	2,901 $20,000
Q4 2017 Feb 14, 2018	SELL	$6.74 - $9.23 $44,484 - $60,918	-6,600 Reduced 55.46%	5,300 $46,000
Q3 2017 Nov 14, 2017	BUY	$5.44 - $7.7 $64,736 - $91,630	11,900	11,900 $77,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $40.6M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.